May 21st 2025
The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.
May 20th 2025
An NEJM study explores how this loss—following Medicaid disenrollment—affects beneficiaries.
May 15th 2025
A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.
May 9th 2025
Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.
May 7th 2025
The move bolsters the CDMO’s commitment to cell and gene therapy by incorporating advanced manufacturing and fill-finish capabilities.